Our Products
Kyowa Kirin International currently has the following medicines available, in different rare disease areas:
Crysvita®
| Generic | Therapy Area |
| Burosumab |
Bone Metabolism |
Poteligeo®
| Generic | Therapy Area |
| Mogamulizumab |
Haemato-oncology |
Libmeldy®
Orchard Therapeutics
| Generic | Therapy Area |
| Atidarsagene autotemcel |
Cell and Gene Therapy |
Links to more details are available on the European Medicines Agency's website.
Copyright © Kyowa Kirin International plc. All rights reserved. This website is developed and funded by Kyowa Kirin International plc.
Head Office Nordics & Baltics:
Kyowa Kirin AB
Torshamnsgatan 39
164 40 Kista
Sweden
Tel: + 46 (8) 50 90 74 10
Kyowa Kirin International plc is a company registered in Scotland (company number SC198780) with registered address at Galabank Business Park, Galashiels TD1 1QH, United Kingdom.
KKI/NORD/KKI/0045 April 2025